5.80
-0.02(-0.34%)
Currency In USD
| Previous Close | 5.82 |
| Open | 5.96 |
| Day High | 6.04 |
| Day Low | 5.8 |
| 52-Week High | 7.6 |
| 52-Week Low | 4.28 |
| Volume | 2,689 |
| Average Volume | 20,253 |
| Market Cap | 52.47M |
| PE | 20.71 |
| EPS | 0.28 |
| Moving Average 50 Days | 5.75 |
| Moving Average 200 Days | 5.93 |
| Change | -0.02 |
If you invested $1000 in ImmuCell Corporation (ICCC) 10 years ago, it would be worth $768.21 as of December 24, 2025 at a share price of $5.8. Whereas If you bought $1000 worth of ImmuCell Corporation (ICCC) shares 5 years ago, it would be worth $928 as of December 24, 2025 at a share price of $5.8.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
GlobeNewswire Inc.
4 hours ago
PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity today announced that it recei
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025
GlobeNewswire Inc.
Nov 06, 2025 9:05 PM GMT
Conference Call Scheduled for Friday, November 14, 2025 at 9:00 AM ETPORTLAND, Maine, Nov. 06, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures a
ImmuCell Announces Onboarding of New CEO and Related Management Changes
GlobeNewswire Inc.
Nov 04, 2025 9:05 PM GMT
PORTLAND, Maine, Nov. 04, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve